Active Not Recruiting NA INTERVENTIONAL 2-arm NCT06217328

RESTORE: An RCT to Evaluate the Efficacy of the Revi System

A Prospective Randomized Control Trial to Compare the Efficacy of the Revi System Therapy on Versus Off in Relieving Urinary Urge Incontinence Episodes.

Sponsor: BlueWind Medical

Conditions Urinary Urge Incontinence

Interventions Revi System - Delayed Activation Revi System Treatment

Updated 8 times since 2024 Last updated: Dec 15, 2025 Started: Feb 24, 2024 Primary completion: Feb 28, 2026 Completion: Feb 28, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06217328, this NA trial focuses on Urinary Urge Incontinence and remains ongoing. Sponsored by BlueWind Medical, it has been updated 8 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Sep 2025 — Jan 2026 [monthly]

Recruiting NA
Jan 2025 — Sep 2025 [monthly]

Recruiting NA
Sep 2024 — Jan 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA

▶ Show 3 earlier versions

May 2024 — Jul 2024 [monthly]

Recruiting NA
Apr 2024 — May 2024 [monthly]

Recruiting NA
Feb 2024 — Apr 2024 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BlueWind Medical

Data source: BlueWind Medical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arlington, United States , Chicago, United States , Cleveland, United States , Dallas, United States , Durham, United States , Edinburg, United States , Lombard, United States , Omaha, United States , Owings Mills, United States , Pasadena, United States and 9 more locations